Aquatic Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-47,800
Closed -$12.5M 1242
2024
Q4
$12.5M Buy
47,800
+31,000
+185% +$9.2M 0.34% 73
2024
Q3
$5.41M Buy
+16,800
New +$5.5M 0.14% 183
2024
Q1
Sell
-520
Closed -$150K 1196
2023
Q4
$150K Buy
+520
New +$142K ﹤0.01% 914
2023
Q3
Sell
-25,400
Closed -$5.64M 1218
2023
Q2
$5.64M Buy
25,400
+25,100
+8,367% +$5.82M 0.31% 78
2023
Q1
$73K Sell
300
-22,700
-99% -$5.57M ﹤0.01% 812
2022
Q4
$6.04M Sell
23,000
-26,800
-54% -$7.18M 0.44% 43
2022
Q3
$11.2M Buy
49,800
+39,800
+398% +$9.65M 1.09% 9
2022
Q2
$2.43M Buy
+10,000
New +$2.45M 0.79% 19
2022
Q1
Sell
-800
Closed -$180K 1061
2021
Q4
$180K Buy
+800
New +$169K 0.35% 45

Other funds holding AMGN

Aquatic Capital Management's AMGN Position: Q1 2025 in Review

Aquatic Capital Management sold out of Amgen (AMGN) in Q1 2025, closing a stake of 47,800 shares — an estimated $12.5M sold.

Aquatic Capital Management first reported a position in AMGN in Q4 2021 and held it in 9 quarters. The position peaked at $12.5M in Q4 2024. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Aquatic Capital Management reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • Aquatic Capital Management sold 47,800 Amgen shares in Q1 2025, an estimated $12.5M.
  • Aquatic Capital Management first reported a position in Amgen in Q4 2021 and held it in 9 quarters.
  • Aquatic Capital Management's Amgen position peaked at $12.5M in Q4 2024.
  • 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Aquatic Capital Management's 13F filing for Q1 2025, filed 15 May 2025.